More Evidence Cannabinoid THCV Helps with Type 2 Diabetes

The alarming increase in diabetes, especially behavior-linked Type 2 diabetes, threatens this nation’s and the planet’s health care systems. With this disease, the body is unable to process enough sugar from the blood. This excess blood glucose damages nearly every organ and normal health process, causing much misery, and in some cases disabilities, amputations, blindness, and impotence. The disease doubles risk of early death.

New evidence helps establish the usefulness in the plant cannabinoid, THCV (tetrahydrocannabivarin), in helping control Type 2 diabetes. As reported previously in this blog, THCV appears to help less obesity.  A new study, reported by the International Association for Cannabinoid Medicines, appears soon in Diabetes Care. 2016 Aug 29. pii: dc160650. Titled, Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study, shows he beneficial effects on a number of diabetic indices.

Significantly, the authors found that “Compared with placebo, THCV significantly decreased fasting plasma glucose.” This removal of sugar from the blood is a basic goal of diabetes prevention and treatment. Additionally, they found improvements in:

  • Pancreatic β-cell function
  • Adiponectin levels
  • Apolipoprotein A

The authors assert in conclusion:

THCV could represent a new therapeutic agent in glycemic control in subjects with type 2 diabetes.

Seminal cannabis researcher and discoverer of THC, Raphael Mechoulam, in British Journal of Pharmacology in 2005, discussed the apparent unique properties of THCV and posed several research questions. He notes, as has Scottish researcher Roger G. Pertwee, that THCV content can be very high in hashish from Pakistan. Despite these high levels of the supposed CB1 receptor antagonist THCV, Pakistani hashish has no apparent “downer” aspect depressing the user. Perhaps this is due to the presence of the other 60 cannabinoids.

Use of THCV as medical marijuana for obesity and diabetes prevention and treatment is made difficult by the lack of access to THCV-heavy or predominant strains. Durban Poison is probably the most available. Reviewer Ry Richard gave it kudos for energy.

“Durban is legendary for its almost electric effects package, which fills the user with a buzzing energy and a flurry of mental activity. It is the perfect variety for a productive day, as it is strong but tends to stay out of the way of most mental processes, allowing for a high level of functionality.”

Such high levels of energy could come in handy in assisting with other behavioral and lifestyle factors affecting glucose levels and other metabolic processes. Human bodies overly composed of fat cells and lacking in muscles cells become insulin resistant and cannot remove sufficient blood sugar. Lack of movement, such as prolonged sitting is a major metabolic risk factor on its own, causing “sitting diseases” of which obesity is one and diabetes another.

Physical movement, such as walking at least 10,000 steps a day, provides powerful preventive and treatment effects for pre-diabetics and those with the actual diagnosis. Adequate walking helps control excess fat while building muscle, and provides dozens of preventive health benefits. Jogging a few minutes per day in addition helps even more.

Muscle mass and muscle cells readily accept and burn glucose, removing it from the blood stream and turning it into energy instead of poison. In addition to movement, engaging in weight training or other muscle building regimen for just a few minutes every other day can quickly help build muscle mass to pull glucose from the blood and burn it up. By burning this energy, muscle mass also helps control obesity and, besides, looks darn good!

Help prevent and even treat diabetes and obesity with low sugar intake and high THCV cannabis, along with movement and muscle.

The Cannabinoid THCV May Treat Acne

Cannabis is a treasure trove of medicines. The plant’s 80+ cannabinoids offer treatment and relief from a long list of maladies: acne may now be included. The cannabinoid TCHV may offer a powerful treatment for acne, according to new European research.

Acne is an inflammation of the sebaceous glands, often on the faces of teenagers.    The gland’s duct can become blocked, perhaps from excess sebum produced by teenage hormones. Blocked glands can suffer bacterial infection, producing the common, if distressing, lesions on the skin.

Earlier, this same group found potential for the cannabinoid CBD (cannabidiol) in acne treatment.  Published in the Journal of Clinical Investigation, they concluded,

Collectively, our findings suggest that, due to the combined lipostatic, antiproliferative, and antiinflammatory effects, CBD has potential as a promising therapeutic agent for the treatment of acne vulgaris.”

The researchers followed up by studying five other cannabinoids as possible treatment of acne and related skin conditions. THCV, (-)-Δ9 -tetrahydrocannabivarin, CBC, CBDV, CBGV and CBD. They found different effects: CBG and CBGV may help in the treatment of dry skin. Concerning the opposite problem, excess lipogenesis and acne, the researchers found that:

CBC, CBDV and especially THCV show promise to become highly efficient, novel anti-acne agents. Moreover, based on their remarkable anti-inflammatory actions, phytocannabinoids could be efficient, yet safe novel tools in the management of cutaneous inflammations.

Cannabinoid Receptors Help Reduce Parkinson’s Disease (PD) Inflammation

Our body’s natural cannabinoid receptors may play an important role in reducing inflammation in Parkinson’s Disease (PD).

Parkinson's disease patient showing a flexed w...

Parkinson’s disease patient showing a flexed walking posture pictured in 1892. Photo appeared in Nouvelle Iconographie de la Salpètrière, vol. 5. (Photo credit: Wikipedia)

Once again, ground breaking cannabinoid research is announced by researchers at Madrid’s Complutense University. Chronic inflammation anywhere in our bodies is a destructive process; in the brain it is particularly insidious. “Inflammation is an important pathogenic factor in Parkinson’s disease (PD),” remind the Spanish researchers in this new study. Inflammation can “kill dopaminergic neurons of the substantia nigra and to enhance the dopaminergic denervation of the striatum.”

Among the many functions of your endocannabinoid system is control of inflammation., and more generally, protecting nerve cells (neuroprotection). Your cannabinoid system activates from interaction with your natural endocannabinoids such as anandamide. Plant cannabinoids such as THC and CBD, and synthesized research cannabinoids can also modulate your endocannabinoid system, through its receptors CB1 and CB2, (and other receptors and processes).

This new Spanish research focused on receptor CB2.

Unlike CB1 receptors which are found primarily in the outer layer of neurons in the brain and throughout the body, CB2 receptors are more associated with the immune system. This research looked at CB2 in brain cells, not in neurons, but in microglia support cells. About one out of seven of your total brain cells are these microglia immune cells; macrophage-like, they serve as a sensitive as house-keepers, removing damaged neurons and other waste material. When need be, microglial cells mount a powerful protective force against bacterial and other threats to your neurons.

The Spaniards write:

The cannabinoid type-2 (CB2) receptor has been investigated as a potential anti-inflammatory and neuroprotective target in different neurodegenerative disorders, but still limited evidence has been collected in PD. Here, we show for the first time that CB2 receptors are elevated in microglial cells recruited and activated at lesioned sites in the substantia nigra of PD patients compared to control subjects.

In an earlier study, some of the same researchers examined the possible use of the cannabinoid THCV (tetrahydrocannabivarin) . See Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease. Again, activation of CB2 receptors was the focus. The researchers concluded:

Given its antioxidant properties and its ability to activate CB(2) but to block CB(1) receptors, Δ(9)-THCV has a promising pharmacological profile for delaying disease progression in PD and also for ameliorating parkinsonian symptoms.

De-scheduling is the new Rescheduling: Moving the Cannabis Reform Goalposts

The draconian Schemarijuana and pillsdule I status of cannabis in federal drug law for the last half century has been of one country’s most harmful deceits. For decades cannabis reformers have sought to have marijuana down scheduled from the totally restrictive Schedule I, to Schedule II. But any simple rescheduling still would leave cannabis an illegal federal drug. Much better, and now on the table, is  de-scheduling, removing marijuana from the Controlled Substances Act (and the clutches of the DEA). Cannabis could be and should be classified with alcohol and cigarettes, even though it is far safer than these legal substances.

Schedule I

The marijuana-law reforming CARERS Act, now languishing at the neglect of Senator Chuck (Ghastly) Grassley, seeks to down-schedule cannabis from Schedule I to Schedule II. This single step has been a long-sought goal of reformers and would be significant; many of the worst legal harms would be removed by that modest rescheduling. Research on health benefits of cannabis would become possible, as marijuana would no longer be defined as medically useless. Mandatory minimum sentences, enforced because of cannabis’ Schedule I status, would no longer apply.

Still, cannabis does not belong in Schedule II, with cocaine and other harsher drugs. Also, the IRS 280e regulation that inflicts severe tax impacts on marijuana businesses, would still be in play. Banking would remain impossible. Cities and counties in legal states could still prohibit, relying on the argument that it is against federal law.

The DEA itself down-scheduled synthetic marijuana in the form of the pharmaceutical pill, to Schedule III. Ironically, Marinol is 100% THC, far stronger than the strongest pot, and taken as a pill without the dose management capabilities of smoking or vaping. This down-scheduling, by the way, belies President Obama’s assertion that he could not reschedule should he so choose. The DEA, after all, is part of the Justice Department, which in turn reports to the president.

Even down-scheduling to Schedule IV or Schedule V would place cannabis with substances far more dangerous. Nearly any drug can kill; cannabis cannot kill. The main problem with cannabis being scheduled at all in the Controlled Substance Act is with that status cannabis remains a federally illegal drug.

Descheduling Cannabis

Marijuana never should have been a federally criminally controlled drug; it must not continue to be so in the future.

Although the fit is far from perfect, cannabis could be more fairly government regulated if it were treated like alcohol and cigarettes. These two supposed non-drugs are in fact the most dangerous, and kill millions around the planet each year. Cannabis kills zero each year world wide. Still, such a classification, out of the Controlled Substance Act and out of the hands of the DEA, would enable intense medical marijuana research and an entrepreneurial boom. The Bureau of Alcohol, Tobacco, Cannabis, and Firearms could be the regulatory agency.

One Presidential Candidate Supports De-Scheduling: Senator Bernie Sanders

As reported in, the presidential candidate recently proposed the Ending Marijuana Prohibition Act of 2015. Marijuana Policy Project’s Mason Tvert is quoted:

Sen. Sanders is simply proposing that we treat marijuana similarly to how we treat alcohol at the federal level, leaving most of the details to the states. It is a commonsense proposal that is long overdue in the Senate

Lacking passage of this bill, exactly how cannabis gets totally de-scheduled is questionable. Were Bernie Sanders to attain the presidency, he could down-schedule to the least restrictive Schedule V. But whether he could remove cannabis from the Controlled Substances Act on this own, without congressional agreement, is unclear.



“Concussion” Is Teachable Moment For Cannabis And Brain Trauma

Will Smith - Concussion

Will Smith – Concussion

Cannabis reduces traumatic brain injury!

Far too few know this benefit of medical marijuana use and treatment. The general public, the NFL, and coaches across the country may soon get that opportunity.

The SONY movie, “Concussion,” examining brain trauma in the NFL, presents a unique opportunity to educate about benefits of cannabis for traumatic brain injury. Will Smith plays a forensic pathologist who discovers the chilling extent of chronic traumatic encephalopathy (CTE) in NFL players, setting them up for depression, dementia, and early death.

The Christmas 2015 movie has already elevated the issue of traumatic brain injury to the public and NFL players. Although the movie does not address how cannabis can minimize brain injuries, the time will be ripe for such education.

Dr. Lester Grinspoon may be the best educator on this timely issue.

This a retired Harvard psychiatrist and pioneering authority on marijuana’s medical benefits has already specifically addressed the issue of CTE in the NFL, when he petitioned  the organization to fund research into cannabis and brain trauma. Dr. Grinspoon has been educating on the positive health effects of cannabis for decades, since it helped his son with cancer in the 1970s. He has written a dozen books, several on medical marijuana, calling it The Forbidden Medicine.”  He has editorialized in The New York Times that marijuana is a “wonder drug“, where he lists the truly wondrous medical benefits provided, including relief from neuropathic pain. He writes:

If marijuana were a new discovery rather than a well-known substance carrying cultural and political baggage, it would be hailed as a wonder drug.


Cannabis and Brain Injury

Head injury and traumatic brain accident. Fotolia

Head injury and traumatic brain accident. Fotolia

Much of the research showing the protective effects of cannabinoids against traumatic brain injury comes from Israel. Studies reported in 2013 in this small, high-tech country showed that THC and similar cannabinoids can reduce injury both before and after trauma.

Irony alert: This research showing the brain-protective benefits was done at the Adelson Center for the Biology of Addictive Diseases. Sheldon Adelson, that is, the American right-wing gambling billionaire and major benefactor to Israel. Ironically, he put several million dollars into a 2014 Florida campaign to PREVENT medical marijuana in that state. With the help of his money, Floridians were denied the benefits of medical cannabis, such as reducing brain injury and dementia, discovered in his own center! WTF?

Other Israeli researchers concentrated on 2-AG, the human body’s own cannabinoid molecule, along with anandamide, that fits lock-and-key into the same receptors activated by plant cannabinoid in marijuana. They discuss how cannabinoids work on the biological and molecular levels to reduce traumatic brain injury (TBI) and with it minimize the disabling disease CTE. The brain trauma of a concussive hit does not all take place and finish with the hit. In the hours following, inflammation is a destructive factor, caused in part by cytokines, cell messengers, such as the dangerous TNF-alpha, IL-6, and IL-1beta. 2-AG also reduces blood brain barrier (BBB) permeability, another neuroprotective effect.

More ways cannabinoids reduce traumatic brain injury.

Head trauma, such as a massive acceleration/deceleration of a head during helmet to pad collision, common in NFL football, begins a lengthy neurological response process, often inflicting more harm to the brain. This response is primarily inflammatory. For a specific site, even the whole brain, the culprit is “excitotoxicity, the pathological process by which nerve cells are damaged or killed by excessive stimulation by neurotransmitters such as glutamate and similar substances.” This neurotransmitter overload degrades and kills brain cells, and they die a messy death, creating further toxicity in the form of Reactive Oxygen Species (ROS), nasty molecules that damage cell structures and your DNA.

So as soon as a football player takes a concussive hit, from then for hours, and longer,  the resulting excitotoxicity attacks neurons and other cells:

  • Dangerous cytokines deliver massive numbers of inflammatory molecules.
  • Glutamate increases wildly, along with other neurotransmitters.
  • NMDA receptors are activated by excess glutamate which causes a flow of calcium and sodium into cells, generating free radicals.
  • Dying mitochondria, the cell’s powerhouse release toxic Reactive Oxygen Species (ROS), bully molecules swinging dangerous free radical electrons, and smashing up nerve cells.
  • Vasoconstriction reduces blood flow to the brain.

Amazingly, cannabinoids in cannabis exert a healing calm to excitotoxicity and help reduce neurological damage in all areas.

  • Antioxidants action: Even without activating the  endocannabinoid system, cannabinoids themselves are potent anti-oxidants, the perfect remedy to the oxidative stress, as they neutralize these rowdy ROS molecules.
  • Retrograde signalling, found only in the endocannabinoid system, calms neuronal firings with “backwards” retrograde signaling across synapses to reduce nerve cell activity.
  • Apoptosis, cell death is reduced, lowering the resulting volume of inflammatory molecules.
  • Cannabinoids promote vasodilation, restoring healing blood flow to the brain by counteracting the endothelin (ET-1)-induced vasoconstriction that aggravates brain damage.
  • Anti-inflammatory actions are all neuroprotective. And they result in reduced brain swelling.

So, obviously, the investigation of cannabis in reducing traumatic brain injury and CTE in football players and sports participants who suffer concussions presents a life-saving opportunity. Their are ample reasons for undertaking this research and hopefully the NFL will take up Dr. Grinspoon’s challenge to fund it.

First, do no harm. The NFL’s knee jerk mandate of prohibiting cannabis use by players may be doing huge harms by denying them the medicine that can help prevent, treat, and minimize injuries from the brain trauma they suffer as players.

Beyond that, what can we do as fans of football, and for some, as parent of young players, to help get the NFL to sponsor this vitally needed research into concussion and cannabis?.

Copyright © 2015  Don Fitch


Cannabis Fights Alzheimer’s and Dementia

Cannabinoids may well be helpful in slowing and preventing the damage to the human brain known as Alzheimer ’s disease and other dementia.

With properties that help protect nerve cells, especially brain cells, it is reasonable that cannabinoids might be useful in preventing and treating insidious AD.

English: Diagram of how microtubules desintegr...

English: Diagram of how microtubules desintegrate with Alzheimer’s disease

As with other degenerative diseases associated with aging, AD is of special importance to baby boomers and aging populations throughout the world.The number of people so afflicted may triple over the next half century. All the degenerative diseases are cruel, but AD can inflict soul-robbing pathology into families and relationships. With AD comes a slow breakdown of memories and then personality.

Plaques and Tangles

Central to this damage seems to be the formation of fibrous, knotted senile plaques in the brain. Inside these plaques, inflammation festers. Chronic inflammation is dangerous anywhere; it is especially destructive when microglial cells, the brain’s protectors, themselves become sources of inflammation right in the brain.

Two protein substances clog the brains of those afflicted with AD. Remarkably, cannabinoids appear to provide protection against both these threats to our brains and minds.

  1. Amyloid plaques – composed of strands of protein, beta-amyloid peptides. These so-called senile plaques are a clear marker for Alzheimer ’s disease.
  2. Neurofibrillary tangles – composed of protein microtubules, tau.

THC Blocking Plaques

Fresh research reported in late 2006 clarifies some of the mechanisms that make THC such a powerful anti-Alzheimer’s disease agent. San Diego’s Scripps Research Institute, specifically its Worm Institute of Research and Medicine is the source of new findings about the ability of THC to block the formation of plaques in the brain. In test tube trials, THC shows a remarkable ability to stop the formation of these personality-robbing plaques. THC, the San Diego researchers found, inhibited the enzyme acetylcholinesterase, a substance that plays a key role in inducing β amyloid plaques.

Side-by-side comparisons with two pharmaceutical drugs currently on the market (and inexorably advertised during television news) are startling. THC, the primary cannabinoid from the source plant cannabis. was over four times more effective than one of the drugs, and roughly 14 times more effective than the other.

At the molecular level, THC bound to the acetylcholinesterase molecule, preventing the enzyme’s key role in creation of amyloid aggregation. Institute director and study coauthor Kim Janda was quite effusive at a 2006 release:

Although our study is far from final, it does show that there is a previously unrecognized molecular mechanism through which THC may directly affect the progression of Alzheimer’s disease.

Lead researcher Janda went on to say,

While we are certainly not advocating the use of illegal drugs, these findings offer convincing evidence that THC possesses remarkable inhibitory qualities, especially when compared to [Alzheimer’s drugs] currently available to patients.


Look for Part 2 soon at Your Brain on Bliss


CBD Better With Other Entourage Cannabinoids

Cannabidiol (CBD) ©-designer491 Fotolia

Cannabidiol (CBD) ©-designer491 Fotolia

CBD, the medically remarkable cannabinoid from marijuana works much better with other cannabinoids in ‘entourage.’ My last post covered some of the political wrangling, with some states passing CBD-only laws and thinking they are done with medical marijuana. This entourage effect proves them wrong, and show that whole plant extracts with multiple cannabinoids, especially THC, work far better than CBD-only medications.

A major problem with CBD-only medication is a bell-shaped dose-response. The authors of the new Israeli study point out that CBD, short for cannabidiol, provided powerful anti-inflammatory and pain relief when delivered orally or intraperitoneally, but the effect seemed highly dose-dependent. Too high or too low a dose of purified CBD provided less effect against inflammation and pain, making establishing dosing very difficult.

This problem was solved by using “plant extracts derived from the Cannabis sativa L., clone 202, which is highly enriched in CBD,” in other words, high CBD marijuana. The effects were spectacular:

In stark contrast to purified CBD, the clone 202 extract, when given either intraperitoneally or orally, provided a clear correlation between the anti-inflammatory and anti-nociceptive responses and the dose, with increasing responses upon increasing doses, which makes this plant medicine ideal for clinical uses.

Such powerful, predictable, and reproducible pain and inflammation relief enable clinicians to set dosages, a key need in using cannabis medicine.

Have you tried CBD or CBD with entourage cannabinoids for any condition? What were your results?

Related articles

Cannabis Entourage Medically Superior to CBD Alone

Medical CannabisCBD is a remarkably medically potent component of marijuana. One of over 60 cannabinoids, CBD, short for ‘cannabidiol,‘ has dozens of medical uses, including anti-seizure, anti-inflammation, anti-anxiety, antioxidant, anti-tumor and as treatment for pain. But new research confirms what has long been thought: CBD in addition to other entourage cannabinoids like THC is far superior medically to pure CBD.

Cannabidiol does not produce the ‘high’ associated with THC, another medically useful cannabinoid. This lack of psychotropic effect from CBD is highly esteemed by researchers (and politicians), if not necessarily by the patient.

Dr. Sanjay Gupta brought to awareness for many Americans his conversion to supporting medical cannabis and research and reporting on CBD treatment of intractable seizures in children.  The effectiveness of CBD to quiet seizures heretofore unstoppable by a flood of truly toxic drugs has led to the spectacle of, in America, of medical refugees having to leave their harsh home states and head to legal Colorado.

In the USA many state legislators, although often abhorrent to marijuana, have been unable to resist the logic of supplying this safe but effective anti-seizure medication to children in their states. Sometimes shamed by families testifying with their seizure-inflicted chidren many states have passed CBD-only (or low THC) availability laws. (Bizarrely, by doing so, states are violating federal law, as CBD remains a  Schedule I substance, deemed harmful and without medical value, and most worthy of harsh control. But that remains topic for another day.)

The danger here is that state legislators may then feel that they have done their part in supplying medical marijuana by giving CBD the OK, will resist widening choices even in light of evidence that “entourage” cannabis medications are superior.

The Israeli research, with important implications for dosing medical cannabis is linked below. It will soon be detailed in another post:

Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol



Cannabis Oil: A Medical Marvel For Your Skin?

Back massageAs medical and personal use of marijuana become increasingly legal, many new ways to intake cannabis are now available. In addition to inhaling smoke, people can benefit from the medical cannabinoids in cannabis by vaporizing, ingesting, and absorption via the skin.

Plant cannabinoids, such as THC and CBD,  are fat soluble and readily absorbed by the skin. These medicinal molecules may well be most perfectly administered, for many conditions, via topical products applied directly to the skin’s surface, such as cannabis-infused massage oil. To clarify, this is not “hemp oil” from the seeds of low cannabinoid hemp, but made from the flowers (buds) themselves, and filled with cannabinoids.

© freshidea -

© freshidea –

The importance of the endocannabinoid system (ECS) to the healthy functioning of the skin is only now becoming clear, as the profound ways the ECS effects all our systems are continually discovered. This system,with natural receptors (CB1 and CB2) found in brain, immune and most types of cells, including those in the skin, and natural endocannabinoids our bodies produce, are perhaps the greatest discoveries in human physiology of the last 50 years.

During these same time, researchers discovered the ability for plant based cannabinoids from cannabis, including THC and  CBD, to activate the ECS.  These cannabinoids offer great potential for preventing, treating, and curing common skin diseases. Massages using cannabis infused oil may be an optimal way to address skin maladies. Cannabinoids may be very useful in treating skin cancer.

The endocannabinoid anandamide (AEA) has been found to play a key role in the health of the skin, prompting these Italian researchers to study cannabinoids cannabidiol (CBD), cannabigerol (CBG), and  cannabidivarin (CBDV) to study effects on skin cells. The Italian study skipped THC because of its psychoactivity, but THC has been shown to be powerfully therapeutic. THC is actually closer to AEA in function than is CBD, so it would have been interesting if it were included in the study.

Many skin conditions are inflammatory in nature and the anti-inflammatory effects of cannabinoids on skin cells have been demonstrated. Both THC and CBD show anti-inflammatory effects.

Cannabinoids also act on the genetic level to help calm skin diseases. The field of Epigenetics studies how “molecular mechanisms in the environment control gene activity independently of DNA sequence.” Activities such as exercise and factors such as nutrition and stress can change how genes are expressed. Endocannabinoids made by your own cells and phytocannabiniods from cannabis sativa also can change genetic expression in medically useful ways, addressing diseases from psoriasis to cancer.

The report concluded: “These findings show that the phytocannabinoids cannabidiol and cannabigerol are transcriptional repressors that can control cell proliferation and differentiation. This indicates that they (especially cannabidiol) have the potential to be lead compounds for the development of novel therapeutics for skin diseases.”

THC infused oils may offer many benefits missing from potions without this main cannabinoid. One of these benefits might be the “psychoactivity” seemingly dreaded by cannabinoid researchers. Patients may well enjoy the blissful experience, and even consider it part of the cure.

Watch for Part 2 of this series for more on the science, on the new found epigenetic capabilities of cannabinoids, how marijuana’s amazing molecules adjust gene expression to protect skin.

Congressman Steve Cohen Calls for End of Schedule I for Cannabis

By Don Fitch

Steve Cohen

Congressman Steve Cohen

Steve Cohen, US Congressman from Tennessee, has called out Attorney General Eric Holder to end the ludicrous Schedule I legal status for cannabis. The Tennessee democrat (TN-09) is one of several US congresspersons working against continued marijuana prohibition.
Congressman Cohen is absolutely right when he speaks about the evils of Schedule I status, the most restrictive and punitive, for cannabis and hemp. These negatives include:

• Asset Forfeiture: Schedule I means marijuana “crimes” are among the most serious federal offenses, enabling draconian stealing of personal assets by the government.

• IRS 280E: This rule may cripple most cannabis businesses by disallowing common business deductions because of the illegality (especially Schedule I) of the product.

• Mandatory Minimums: Long prison terms for any “crime” involving cannabis are supported by the pernicious Schedule I tag.

• Medical Marijuana Research: Total control (and nearly total restriction) is granted to the DEA and NIDA, who cling to the “no medical use” definition to disallow medical research.

• Hemp: Imported seeds for the first Kentucky hemp planting were delayed at the border by the DEA last summer, requiring the intervention of Kentucky Senator Mitch McConnell. To survive, the new American hemp industry needs cannabis rescheduling. Continue reading